Jakafi

Key claim: Jakafi (ruxolitinib) is used to treat myelofibrosis and polycythemia vera by blocking production of growth factors.

Abstract

This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). It works by blocking your body from producing substances called growth factors.

Why this matters

Jakafi (ruxolitinib) is used to treat myelofibrosis and polycythemia vera by blocking production of growth factors.

Source

Link